Palatin Technologies Inc PTN:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
2.30quote price arrow up+0.01 (+0.43%)
Volume
873
Close
2.29quote price arrow down-0.06 (-2.55%)
Volume
224,305
52 week range
1.43 - 5.65
Loading...
  • Open2.42
  • Day High2.47
  • Day Low2.21
  • Prev Close2.35
  • 52 Week High5.65
  • 52 Week High Date01/29/24
  • 52 Week Low1.43
  • 52 Week Low Date09/28/23

Key Stats

  • Market Cap36.953M
  • Shares Out16.14M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-42.46

KEY STATS

  • Open2.42
  • Day High2.47
  • Day Low2.21
  • Prev Close2.35
  • 52 Week High5.65
  • 52 Week High Date01/29/24
  • 52 Week Low1.43
  • 52 Week Low Date09/28/23
  • Market Cap36.953M
  • Shares Out16.14M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-42.46

RATIOS/PROFITABILITY

  • EPS (TTM)-2.48
  • P/E (TTM)-0.92
  • Fwd P/E (NTM)-1.57
  • EBITDA (TTM)-30.548M
  • ROE (TTM)-1,246.70%
  • Revenue (TTM)7.098M
  • Gross Margin (TTM)95.34%
  • Net Margin (TTM)-435.53%
  • Debt To Equity (MRQ)-0.88%

EVENTS

  • Earnings Date05/15/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Palatin Technologies Inc

 

Profile

MORE
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with unmet medical need and commercial potential. Its new product development activities focus primarily on MC1r agonists, with potential to treat inflammatory and autoimmune diseases, such as dry eye...
John Prendergast
Independent Chairman of the Board
Carl Spana Ph.D.
President, Chief Executive Officer, Director
Stephen Wills CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Address
4B Cedar Brook Drive
Cranbury, NJ
08512
United States

Top Peers

SYMBOLLASTCHG%CHG
BOLT
Bolt Biotherapeutics Inc
1.26+0.14+12.50%
MRKR
Marker Therapeutics Inc
4.20-0.03-0.71%
SPRB
Spruce Biosciences Inc
0.8327-0.0057-0.6799%
LPCN
Lipocine Inc
5.32+0.08+1.53%
TNXP
Tonix Pharmaceuticals Holding Corp
0.1717-0.0103-5.6593%